-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on DexCom, Raises Price Target to $78

Benzinga·12/17/2025 12:57:03
语音播报
Mizuho analyst Anthony Petrone maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $75 to $78.